Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorShanghai Mental Health Center

About this trial

The goal of this clinical trial is to evaluate the efficacy and influencing factors of the combination of the anterior limb of internal capsule and nucleus accumbens (ALIC-NAc) deep brain stimulation (DBS) in patients with treatment-refractory obsessive-compulsive disorder (OCD). The main questions it aims to answer is:

Does the timing of DBS activation (at 1, 2, or 3 months post-surgery) affect the reduction rate in Y-BOCS scores? Researchers will compare three groups-DBS activated at 1, 2, and 3 months post-surgery-to determine whether earlier or later stimulation leads to greater symptom improvement.

Participants will:

* Undergo surgical implantation of an intracranial neurostimulation system targeting ALIC-NAc * Be randomly assigned to one of three DBS activation timing groups * Receive regular clinical assessments over a 6-month follow-up period after activation

Eligibility criteria

Qualifiers

aged 18-65 years old;

a diagnosis of OCD based on The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5);

the Y-BOCS total score ≥ 25;

met the criteria of treatment refractory. Treatment refractory is defined as failed a) Inadequate response or intolerance to at least three adequate trials of selective serotonin reuptake inhibitors (SSRIs), combined with at least two second-generation antipsychotics as augmentation agents.

Disqualifiers

Presence of other psychiatric disorders such as organic mental disorders, paranoid personality disorder, or mental retardation.

Individuals deemed by the investigator to be at significant risk of suicidal behavior based on clinical assessment.

Presence of severe or unstable cardiovascular, respiratory, hepatic, renal, hematologic, endocrine, neurological, or other systemic diseases.

History of organic brain disorders, traumatic brain injury, intractable epilepsy, or other neurological conditions.

Trial design

Treatments tested in this trial

  • deep brain stimulation

Treatment groups

60 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Shanghai Mental Health Center

Lead sponsor

Huashan Hospital

Collaborator

The First Affiliated Hospital of Shanxi Medical University

Collaborator

The First Affiliated Hospital of Nanchang University

Collaborator

Tianjin Anding Hospital

Collaborator

Tianjin Huanhu Hospital

Collaborator

The First Hospital of Hebei Medical University

Collaborator

First Affiliated Hospital of Jinan University

Collaborator

The Second Affiliated Hospital of Xinxiang Medical College

Collaborator

the Third Hospital of Mianyang

Collaborator